The levels of MITF in melanoma are complex, but generally as described by the ‘rheostat’ model: higher levels of MITF are associated with differentiation and proliferation, whereas lower levels are associated with invasion and drug resistance (Goding and Arnheiter, 2019). The gene discussed is MITF; the disease is melanoma.